Cancer in pregnancy: Gaps, challenges and solutions

Cancer Treatment Reviews

Volumn 34, Issue 4, 2008, Pages 302-312

  Pereg, David ^a,d   Koren, Gideon ^b,c   Lishner, Michael ^a,c,d  

^a MEIR MEDICAL CENTER   (Israel)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c Consortium of Cancer in Pregnancy Experience ^*  (Canada)

^d TEL AVIV UNIVERSITY   (Israel)

Author keywords

Breastfeeding; Cancer; Fetus; Malformation; Pregnancy

Indexed keywords

BEVACIZUMAB; BLEOMYCIN; BUSULFAN; CETUXIMAB; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DACARBAZINE; DAUNORUBICIN; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL; IDARUBICIN; IMATINIB; MERCAPTOPURINE; METHOTREXATE; MITOXANTRONE; RITUXIMAB; TRASTUZUMAB; VINBLASTINE; VINCRISTINE;

ABORTION; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER THERAPY; CAUSE OF DEATH; CONGENITAL MALFORMATION; FETUS MATURITY; FIRST TRIMESTER PREGNANCY; HUMAN; NEOPLASM; PATIENT MONITORING; PREGNANCY; PREGNANT WOMAN; PRENATAL EXPOSURE; PROGNOSIS; REVIEW; SECOND TRIMESTER PREGNANCY; THIRD TRIMESTER PREGNANCY; TUMOR GROWTH;

ABNORMALITIES, DRUG-INDUCED; ABORTION, INDUCED; ANTINEOPLASTIC AGENTS; BREAST FEEDING; DECISION SUPPORT TECHNIQUES; DRUG DELIVERY SYSTEMS; ETHICS, MEDICAL; FEMALE; HUMANS; MATERNAL MORTALITY; NEOPLASMS; PREGNANCY; PREGNANCY COMPLICATIONS, NEOPLASTIC; PREGNANCY OUTCOME; PROGNOSIS;

EID: 43949092763     PISSN: 03057372     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ctrv.2008.01.002     Document Type: Review

References (108)

1. Weisz B., Schiff E., and Lishner M. Cancer in pregnancy: maternal and fetal implications. Hum Reprod Update 7 (2001) 384-393
2. Koren G, Lishner M, Santiago S, editors. The Motherisk guide to cancer in pregnancy and lactation. 2nd ed. Toronto, Canada: Motherisk Program; 2005.
3. Pentheroudakis G., and Pavlidis N. Cancer and pregnancy: poena magna, not anymore. Eur J Cancer 42 (2006) 126-140
4. Zemlickis D., Lishner M., Degendorfer P., Panzarella T., Burke B., Sutcliffe S.B., et al. Maternal and fetal outcome after breast cancer in pregnancy. Am J Obstet Gynecol 166 (1992) 781-787
5. Schedin P. Pregnancy-associated breast cancer and metastasis. Nat Rev Cancer 6 (2006) 281-291
6. Ezzat A., Raja M.A., Berry J., Zwaan F.E., Jamshed A., Rhydderch D., et al. Impact of pregnancy on non-metastatic breast cancer: a case control study. Clin Oncol (R Coll Radiol) 8 (1996) 367-370
7. Bonnier P., Romain S., Dilhuydy J.M., Bonichon F., Julien J.P., Charpin C., et al. Influence of pregnancy on the outcome of breast cancer: a case-control study. Societe Francaise de Senologie et de Pathologie Mammaire Study Group. Int J Cancer 72 (1997) 720-727
8. Guinee V.F., Olsson H., Moller T., Hess K.R., Taylor S.H., Fahey T., et al. Effect of pregnancy on prognosis for young women with breast cancer. Lancet 343 (1994) 1587-1589
9. Lethaby A.E., O'Neill M.A., Mason B.H., Holdaway I.M., and Harvey V.J. Overall survival from breast cancer in women pregnant or lactating at or after diagnosis. Auckland Breast Cancer Study Group. Int J Cancer 67 (1996) 751-755
10. Ibrahim E.M., Ezzat A.A., Baloush A., Hussain Z.H., and Mohammed G.H. Pregnancy-associated breast cancer: a case-control study in a young population with a high-fertility rate. Med Oncol 17 (2000) 293-300
11. Travers R.L., Sober A.J., Berwick M., Mihm Jr. M.C., Barnhill R.L., and Duncan L.M. Increased thickness of pregnancy-associated melanoma. Br J Dermatol 132 (1995) 876-883
12. Slingluff Jr. C.L., Reintgen D.S., Vollmer R.T., and Seigler H.F. Malignant melanoma arising during pregnancy. A study of 100 patients. Ann Surg 211 (1990) 552-557
13. Loutfi A., Mather F.J., Carter R.D., Carter R.D., and Krementz E.T. Effect of pregnancy upon malignant melanoma. Surg Gynecol Obstet 157 (1983) 443-446
14. Hopkins M.P., and Morley G.W. The prognosis and management of cervical cancer associated with pregnancy. Obstet Gynecol 80 (1992) 9-13
15. Zemlickis D., Lishner M., Degendorfer P., Panzarella T., Sutcliffe S.B., and Koren G. Maternal and fetal outcome after invasive cervical cancer in pregnancy. J Clin Oncol 9 (1991) 1956-1961
16. Nevin J., Soeters R., Dehaekck K., Bloch B., and van Wyk L. Cervical carcinoma associated with pregnancy. Obstet Gynecol Surv 50 (1995) 228-239
17. Siddiq T.S., Twigg J.P., and Hammond R.H. Assessing the accuracy of colposcopy at predicting the outcome of abnormal cytology in pregnancy. Eur J Obstet Gynecol Reprod Biol 124 (2006) 93-97
18. Lieberman R.W., Henry M.R., Laskin W.B., Walenga J., Buckner S.B., and O'Connor D.M. Colposcopy in pregnancy: directed brush cytology compared with cervical biopsy. Obstet Gynecol 94 (1999) 198-203
19. Weisz B., Meirow D., Schiff E., and Lishner M. Impact and treatment of cancer during pregnancy. Exp Rev Anticancer Ther 4 (2004) 889-902
20. Guerra B., De Simone P., Gabrielli S., Falco P., Montanari G., and Bovicelli L. Combined cytology and colposcopy to screen for cervical cancer in pregnancy. J Reprod Med 43 (1998) 647-653
21. Carter P.M., Coburn T.C., and Luszczak M. Cost-effectiveness of cervical cytologic examination during pregnancy. J Am Board Fam Pract 6 (1993) 537-545
22. Uyar D.S., Eltabbakh G.H., and Mount S.L. Positive predictive value of liquid-based and conventional cervical Papanicolaou smears reported as malignant. Gynecol Oncol 89 (2003) 227-232
23. Eedarapalli P., and Jain S. Breast cancer in pregnancy. J Obstet Gynaecol 26 (2006) 1-4
24. Middleton L.P., Amin M., Gwyn K., Theriault R., and Sahin A. Breast carcinoma in pregnant women: assessment of clinicopathologic and immunohistochemical features. Cancer 98 (2003) 1055-1060
25. Reed W., Hannisdal E., Skovlund E., Thoresen S., Lilleng P., and Nesland J.M. Pregnancy and breast cancer: a population-based study. Virchows Arch 443 (2003) 44-50
26. Lishner M., Zemlickis D., Sutcliffe S.B., and Koren G. Non-Hodgkin's lymphoma and pregnancy. Leuk Lymphoma 14 (1994) 411-413
27. Kal H.B., and Struikmans H. Radiotherapy during pregnancy: fact and fiction. Lancet Oncol 6 (2005) 328-333
28. Benveniste H., Fowler J.S., Rooney W.D., Moller D.H., Backus W.W., Warner D.A., et al. Maternal-fetal in vivo imaging: a combined PET and MRI study. J Nucl Med 44 (2003) 1522-1530
29. Hicks R.J., Binns D., and Stabin M.G. Pattern of uptake and excretion of (18)F-FDG in the lactating breast. J Nucl Med 42 (2001) 1238-1242
30. Ahn B.Y., Kim H.H., Moon W.K., Pisano E.D., Kim H.S., Cha E.S., et al. Pregnancy- and lactation-associated breast cancer: mammographic and sonographic findings. J Ultrasound Med 22 (2003) 491-497
31. Yang W.T., Dryden M.J., Gwyn K., Whitman G.J., and Theriault R. Imaging of breast cancer diagnosed and treated with chemotherapy during pregnancy. Radiology 239 (2006) 52-60
32. Fenig E., Mishaeli M., Kalish Y., and Lishner M. Pregnancy and radiation. Cancer Treat Rev 27 (2001) 1-7
33. International Commission of Radiological Protection. Biological effects after prenatal irradiation. Ann ICRP 33 (2003) 205-206
34. Otake M., and Schull W.J. Radiation-related brain damage and growth retardation among the prenatally exposed atomic bomb survivors. Int J Radiat Biol 74 (1998) 159-171
35. International Commission of Radiological Protection. Pregnancy and medical radiation. Ann ICRP 30 (2000) 1-43
36. Cardonick E., and Iacobucci A. Use of chemotherapy during human pregnancy. Lancet Oncol 5 (2004) 283-291
37. Aviles A., and Neri N. Hematological malignancies and pregnancy: a final report of 84 children who received chemotherapy in utero. Clin Lymphoma 2 (2001) 173-177
38. Hahn K.M., Johnson P.H., Gordon N., et al. Treatment of pregnant breast cancer patients and outcomes of children exposed to chemotherapy in utero. Cancer 107 (2006) 1219-1226
39. Lishner M., Zemlickis D., Degendorfer P., Panzarella T., Sutcliffe S.B., and Koren G. Maternal and fetal outcome following Hodgkin's disease in pregnancy. Br J Cancer 65 (1992) 114-117
40. Pizzuto J., Aviles A., Noriega L., Niz J., Morales M., and Romero F. Treatment of acute leukemia during pregnancy: presentation of nine cases. Cancer Treat Rep 64 (1980) 679-683
41. Taylor G., and Blom J. Acute leukemia during pregnancy. South Med J 73 (1980) 1314-1315
42. Reynoso E.E., Shepherd F.A., Messner H.A., Farquharson H.A., Garvey M.B., and Baker M.A. Acute leukemia during pregnancy: the Toronto Leukemia Study Group experience with long-term follow-up of children exposed in utero to chemotherapeutic agents. J Clin Oncol 5 (1987) 1098-1106
43. Artlich A., Moller J., Tschakaloff A., Schwinger E., Kruse K., and Gortner L. Teratogenic effects in a case of maternal treatment for acute myelocytic leukaemia - neonatal and infantile course. Eur J Pediatr 153 (1994) 488-491
44. Colbert N., Najman A., Gorin N.C., et al. Acute leukaemia during pregnancy: favourable course of pregnancy in two patients treated with cytosine arabinoside and anthracyclines. Nouv Presse Med 9 (1980) 175-178
45. Maurer L.H., Forcier R.J., McIntyre O.R., and Benirschke K. Fetal group C trisomy after cytosine arabinoside and thioguanine. Ann Intern Med 75 (1971) 809-810
46. O'Donnell R., Costigan C., and O'Connell L.G. Two cases of acute leukaemia in pregnancy. Acta Haematol 61 (1979) 298-300
47. Volkenandt M., Buchner T., Hiddemann W., and Van de Loo J. Acute leukaemia during pregnancy. Lancet 2 (1987) 1521-1522
48. Powell H.R., and Ekert H. Methotrexate-induced congenital malformations. Med J Aust 2 (1971) 1076-1077
49. Milunsky A., Graef J.W., and Gaynor Jr. M.F. Methotrexate-induced congenital malformations. J Pediatr 72 (1968) 790-795
50. Feliu J., Juarez S., Ordonez A., Garcia-Paredes M.L., Gonzalez-Baron M., and Montero J.M. Acute leukemia and pregnancy. Cancer 61 (1988) 580-584
51. Kozlowski R.D., Steinbrunner J.V., MacKenzie A.H., Clough J.D., Wilke W.S., and Segal A.M. Outcome of first-trimester exposure to low-dose methotrexate in eight patients with rheumatic. Am J Med 88 (1990) 589-592
52. Donnenfeld A.E., Pastuszak A., Noah J.S., Schick B., Rose N.C., and Koren G. Methotrexate exposure prior to and during pregnancy. Teratology 49 (1994) 79-81
53. Aviles A., Neri N., and Nambo M.J. Long-term evaluation of cardiac function in children who received anthracyclines during pregnancy. Ann Oncol 17 (2006) 286-288
54. Gililland J., and Weinstein L. The effects of cancer chemotherapeutic agents on the developing fetus. Obstet Gynecol Surv 38 (1983) 6-13
55. Zuazu J., Julia A., and Sierra J. Pregnancy outcome in hematologic malignancies. Cancer 67 (1991) 703-709
56. Niedermeier D.M., Frei-Lahr D.A., and Hall P.D. Treatment of acute myeloid leukemia during the second and third trimesters of pregnancy. Pharmacotherapy 25 (2005) 1134-1140
57. Matsuo K., Shimoya K., Ueda S., Wada K., Koyama M., and Murata Y. Idarubicin administered during pregnancy: its effects on the fetus. Gynecol Obstet Invest 58 (2004) 186-188
58. Siu B.L., Alonzo M.R., Vargo T.A., and Fenrich A.L. Transient dilated cardiomyopathy in a newborn exposed to idarubicin and all-trans-retinoic acid (ATRA) early in the second trimester of pregnancy. Int J Gynecol Cancer 12 (2002) 399-402
59. Mulvihill J.J., McKeen E.A., Rosner F., and Zarrabi M.H. Pregnancy outcome in cancer patients. Experience in a large cooperative group. Cancer 60 (1987) 1143-1150
60. Leslie K.K., Koil C., and Rayburn W.F. Chemotherapeutic drugs in pregnancy. Obstet Gynecol Clin North Am 32 (2005) 627-640
61. Zemlickis D., Lishner M., Degendorfer P., Panzarella T., Sutcliffe S.B., and Koren G. Fetal outcome after in utero exposure to cancer chemotherapy. Arch Intern Med 152 (1992) 573-576
62. Doll D.C., Ringenberg Q.S., and Yarbro J.W. Management of cancer during pregnancy. Arch Intern Med 148 (1998) 2058-2064
63. Randall T. National registry seeks scarce data on pregnancy outcomes during chemotherapy. JAMA. 269 (1993) 323
64. Achtari C., and Hohlfeld P. Cardiotoxic transplacental effect of idarubicin administered during the second trimester of pregnancy. Am J Obstet Gynecol 183 (2000) 511-512
65. Sorosky J.I., Sood A.K., and Buekers T.E. The use of chemotherapeutic agents during pregnancy. Obstet Gynecol Clin North Am 24 (1997) 591-599
66. Nulman I., Laslo D., Fried S., Uleryk E., Lishner M., and Koren G. Neurodevelopment of children exposed in utero to treatment of maternal malignancy. Br J Cancer 85 (2001) 1611-1618
67. Pereg D., and Lishner M. Maternal and fetal effects of systemic therapy in the pregnant woman with cancer. Recent Results Cancer Res 178 (2008) 21-38
68. Ault P., Kantarjian H., O'Brien S., Faderl S., Beran M., Rios M.B., et al. Pregnancy among patients with chronic myeloid leukemia treated with imatinib. J Clin Oncol 24 (2006) 1204-1208
69. Fey M.F., and Surbek D. Leukaemia and pregnancy. Recent Results Cancer Res 178 (2008) 97-110
70. Pereg D., Koren G., and Lishner M. The treatment of Hodgkin's and non-Hodgkin's lymphoma in pregnancy. Haematologica 92 (2007) 1230-1237
71. Aebi S., and Loibl S. Breast cancer during pregnancy: medical therapy and prognosis. Recent Results Cancer Res 178 (2008) 45-55
72. Asker C., Norstedt Wikner B., and Kallen B. Use of antiemetic drugs during pregnancy in Sweden. Eur J Clin Pharmacol 61 (2005) 899-906
73. Einarson A., Maltepe C., Navioz Y., Kennedy D., Tan M.P., and Koren G. The safety of ondansetron for nausea and vomiting of pregnancy: a prospective comparative study. BJOG 111 (2004) 940-943
74. Lynch C.M., Sinnott IV J.T., Holt D.A., and Herold A.H. Use of antibiotics during pregnancy. Am Fam Physician 43 (1991) 1365-1368
75. Czeizel A.E., Rockenbauer M., Sorensen H.T., and Olsen J. The teratogenic risk of trimethoprim-sulfonamides: a population based case-control study. Reprod Toxicol 15 (2001) 637-646
76. Werler M.M., Mitchell A.A., Hernandez-Diaz S., and Honein M.A. Use of over-the-counter medications during pregnancy. Am J Obstet Gynecol 193 (2005) 771-777
77. Rudolph A.M. Effects of aspirin and acetaminophen in pregnancy and in the newborn. Arch Intern Med 141 (1981) 358-363
78. Schoenfeld A., Bar Y., Merlob P., and Ovadia Y. NSAIDs: maternal and fetal considerations. Am J Reprod Immunol 28 (1992) 141-147
79. Wunsch M.J., Stanard V., and Schnoll S.H. Treatment of pain in pregnancy. Clin J Pain 19 (2003) 148-155
80. Levy M., and Spino M. Neonatal withdrawal syndrome: associated drugs and pharmacologic management. Pharmacotherapy 13 (1993) 202-211
81. Sifakis S., Angelakis E., Vardaki E., Koumantaki Y., Matalliotakis I., and Koumantakis E. Erythropoietin in the treatment of iron deficiency anemia during pregnancy. Gynecol Obstet Invest 51 (2001) 150-156
82. Cohen-Kerem R., Railton C., Oren D., Lishner M., and Koren G. Pregnancy outcome following non-obstetric surgical intervention. Am J Surg 190 (2005) 467-473
83. Mazze R.I., and Kallen B. Appendectomy during pregnancy: a Swedish registry study of 778 cases. Obstet Gynecol 77 (1991) 835-840
84. Reedy M.B., Kallen B., and Kuehl T.J. Laparoscopy during pregnancy: a study of five fetal outcome parameters with use of the Swedish Health Registry. Am J Obstet Gynecol 177 (1997) 673-679
85. Barone J.E., Bears S., Chen S., Tsai J., and Russell J.C. Outcome study of cholecystectomy during pregnancy. Am J Surg 177 (1999) 232-236
86. Prem K.A., Makowski E.L., and McKelvey J.L. Carcinoma of the cervix associated with pregnancy. Am J Obstet Gynecol 95 (1965) 99-108
87. Thompson J.D., Caputo T.A., Franklin III E.E., and Dale E. The surgical management of invasive cancer of the cervix in pregnancy. Am J Obstet Gynecol 15 (1975) 853-863
88. Lee R.B., Neglia W., and Park R.C. Cervical carcinoma in pregnancy. Obstet Gynecol 58 (1981) 584-589
89. Greer B.E., Easterling T.R., McLennan D.A., Benedetti T.J., Cain J.M., Figge D.C., et al. Fetal and maternal considerations in the management of stage I-B cervical cancer during pregnancy. Gynecol Oncol 34 (1989) 61-65
90. Duggan B., Muderspach L.I., Roman L.D., Curtin J.P., d'Ablaing III G., and Morrow C.P. Cervical cancer in pregnancy: reporting on planned delay in therapy. Obstet Gynecol 82 (1993) 598-602
91. Sorosky J.I., Squatrito R., Ndubisi B.U., Anderson B., Podczaski E.S., Mayr N., et al. Stage I squamous cell cervical carcinoma in pregnancy: planned delay in therapy awaiting fetal maturity. Gynecol Oncol 59 (1995) 207-210
92. Sood A.K., Sorosky J.I., Krogman S., Anderson B., Benda J., and Buller R.E. Surgical management of cervical cancer complicating pregnancy: a case-control study. Gynecol Oncol 63 (1996) 294-298
93. Takushi M., Moromizato H., Sakumoto K., and Kanazawa K. Management of invasive carcinoma of the uterine cervix associated with pregnancy: outcome of intentional delay in treatment. Gynecol Oncol 87 (2002) 185-189
94. Germann N., Haie-Meder C., Morice P., Lhomme C., Duvillard P., Hacene K., et al. Management and clinical outcomes of pregnant patients with invasive cervical cancer. Ann Oncol 16 (2005) 397-402
95. Savitz D.A., Blackmore C.A., and Thorp J.M. Epidemiologic characteristics of preterm delivery: etiologic heterogeneity. Am J Obstet Gynecol 164 (1991) 467-471
96. Ventolini G., Neiger R., Hood D., and Belcastro C. Update on assessment of fetal lung maturity. J Obstet Gynaecol 25 (2005) 535-538
97. O'Meara A.T., Cress R., Xing G., Danielsen B., and Smith L.H. Malignant melanoma in pregnancy. A population-based evaluation. Cancer 103 (2005) 1217-1226
98. Lens M.B., Rosdahl I., Ahlbom A., Farahmand B.Y., Synnerstad I., Boeryd B., et al. Effect of pregnancy on survival in women with cutaneous malignant melanoma. J Clin Oncol 22 (2004) 4369-4375
99. Daryanani D., Plukker J.T., De Hullu J.A., Kuiper H., Nap R.E., and Hoekstra H.J. Pregnancy and early-stage melanoma. Cancer 97 (2003) 2248-2253
100. Gelb A.B., van de Rijn M., Warnke R.A., and Kamel O.W. Pregnancy-associated lymphomas. A clinicopathologic study. Cancer 78 (1996) 304-310
101. Alexander A., Samlowski W.E., Grossman D., Bruggers C.S., Harris R.M., Zone J.J., et al. Metastatic melanoma in pregnancy: risk of transplacental metastases in the infant. J Clin Oncol 21 (2003) 2179-2186
102. Pavlidis N., and Pentheroudakis G. Metastatic involvement of placenta and foetus in pregnant women with cancer. Recent Results Cancer Res 178 (2008) 183-194
103. Matalon S.T., Ornoy A., and Lishner M. The effect of 6-mercaptopurine on early human placental explants. Hum Reprod 20 (2005) 1390-1397
104. DeLoia J.A., Stewart-Akers A.M., and Creinin M.D. Effects of methotrexate on trophoblast proliferation and local immune responses. Hum Reprod 13 (1998) 1063-1069
105. Matalon S.T., Ornoy A., and Lishner M. Review of the potential effects of three commonly used antineoplastic and immunosuppressive drugs (cyclophosphamide, azathioprine, doxorubicin) on the embryo and placenta. Reprod Toxicol 18 (2004) 219-230
106. Pastrakuljic A., Schwartz R., Simone C., Derewlany L.O., Knie B., and Koren G. Transplacental transfer and biotransformation studies of nicotine in the human placental cotyledon perfused in vitro. Life Sci 63 (1998) 2333-2342
107. Boskovic R., Feig D.S., Derewlany L., Knie B., Portnoi G., and Koren G. Transfer of insulin lispro across the human placenta: in vitro perfusion studies. Diabetes Care 26 (2003) 1390-1394
108. Kopecky E.A., Simone C., and Koren G. Transfer of morphine across the human placenta and its interaction with naloxone. Life Sci 65 (1999) 2359-2371